OCCUPATIONAL THERAPY CREATES PROFOUND IMPACTS ON CLIENT AND PATIENT LIVES
Margeaux Bartholomew-Carle
Occupational Therapist &
Chief Executive Officer, Ardant
PEOPLE IN HEALTH CARE
Filmed in Adelaide, South Australia | December 2024
In Australia, access to allied health services such as occupational therapy is increasingly challenging. Barriers like long wait times affect over 600,000 National Disability Insurance Scheme (NDIS) and 1.5 million aged care participants. With both cohorts expected to grow exponentially in coming years, the pressure on an already stretched system is set to increase.
Australian Health Journal met with one Occupational Therapist who encourages those entering the profession to embrace continuous learning and seek mentorship to maximise their impact on clients’ lives. Through her company she has a nation-wide mission to transform client access to allied health services like occupational therapy using artificial intelligence (AI).
Margeaux Bartholomew-Carle is an Adelaide based registered Occupational Therapist and the Founder and CEO of Ardant.
Throughout her career, Margeaux has worked in various settings, including aged care, disability, assistive technology, prescription, and mental health. This diverse experience has deepened her understanding of the different needs among client groups.
A significant turning point came when she worked as a solo practitioner and realised that the heavy administrative burden often kept her from important family moments, especially while her father was in the hospital with advanced prostate cancer. This experience motivated her to establish Ardant, focused on enabling OTs to prioritise client care over administrative tasks.
Under her leadership, Ardant has created an all-in-one online practice management platform designed to reduce administrative burdens for independent occupational therapists across Australia, ultimately enhancing access to OT services and improving client outcomes.
Margeaux believes that the role of occupational therapists is gaining recognition, particularly with the introduction of the NDIS, but acknowledges there are persistent misconceptions about the profession. To raise awareness, she advocates for targeted campaigns to educate GPs, health professionals, and the public about the value of OT in primary healthcare.
-
Developing the nation’s first Health and Medical Research Strategy
Professor Steve Wesselingh serves as the CEO of NHMRC, having initially trained as an infectious diseases doctor. His career includes prominent roles such as Head of the Infectious Diseases Unit at the Alfred Hospital, Director of the Burnett, Dean of Medicine at Monash University, and the inaugural Director of SAHMRI. Under his leadership, NHMRC plays a critical role in funding health and medical research, allocating approximately a billion dollars annually to investigator-led projects, clinical trials, and various strategic initiatives. NHMRC also collaborates internationally with organisations such as the MRC and the EU, and manages grant allocation for the MRFF, which distributes $650 million each year.
-
The desire for primary care nurses to do more, be recognised and valued for the work they do
Denise Lyons is a highly experienced nurse with over 40 years in the profession, including more than 25 years dedicated to primary care. She earned her Bachelor of Science in Nursing in the United States in 1985 and, in 2012, became an endorsed Nurse Practitioner in Australia. Currently, she serves as a primary care Nurse Practitioner in General Practice in Newcastle, where she is committed to delivering high-quality, patient-centred care that improves the health and wellbeing of her community.
-
Making clinical trials participant friendly
Clinical trials are essential in developing new, improved, and more effective treatments and interventions. Without trials, researchers and professionals in the field cannot properly determine whether these new treatments and interventions are safe and effective.
The Clinials platform is geared towards patient centric trials and reducing site burden. The aim is to accelerate lifesaving medicines coming to market by connecting participants and researchers. The platform allows participants to come to researchers with their eligibility in hand among other capabilities.
